aristolochic acid i and losartan potassium

aristolochic acid i has been researched along with losartan potassium in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wang, W; Zhang, J1
Aoki, T; Hamano, Y; Hatano, M; Kimura, R; Ogawa, M; Shirai, R; Ueda, S; Yokosuka, O1
Angeletti, A; Cantarelli, C; Cravedi, P; D'Agati, VD; Donadei, C; Fiaccadori, E; Guglielmo, C; Hartzell, S; Heeger, PS; Horwitz, JK; La Manna, G; Madsen, JC; Maggiore, U; Xiong, H1

Other Studies

3 other study(ies) available for aristolochic acid i and losartan potassium

ArticleYear
Protective effect of erythropoietin against aristolochic acid-induced apoptosis in renal tubular epithelial cells.
    European journal of pharmacology, 2008, Jul-07, Volume: 588, Issue:2-3

    Topics: Animals; Apoptosis; Aristolochic Acids; bcl-X Protein; Caspase 3; Cells, Cultured; Cytoprotection; DNA Fragmentation; Epithelial Cells; Erythropoietin; In Situ Nick-End Labeling; Kidney Tubules; LLC-PK1 Cells; Proliferating Cell Nuclear Antigen; Recombinant Proteins; Swine

2008
Low-dose darbepoetin alpha attenuates progression of a mouse model of aristolochic acid nephropathy through early tubular protection.
    Nephron. Experimental nephrology, 2010, Volume: 114, Issue:2

    Topics: Animals; Apoptosis; Aristolochic Acids; Cell Proliferation; Darbepoetin alfa; Disease Models, Animal; Erythropoietin; Fibrosis; Kidney Tubular Necrosis, Acute; Kidney Tubules; Male; Mice; Mice, Inbred C3H

2010
Erythropoietin inhibits SGK1-dependent TH17 induction and TH17-dependent kidney disease.
    JCI insight, 2019, 04-23, Volume: 5

    Topics: Animals; Aristolochic Acids; Cells, Cultured; Disease Models, Animal; Epoetin Alfa; Erythropoietin; Female; Humans; Immediate-Early Proteins; Interleukin-17; Lupus Nephritis; Male; Mice; Mice, Inbred MRL lpr; Mice, Transgenic; Nephritis, Interstitial; Phosphorylation; Primary Cell Culture; Protein Serine-Threonine Kinases; Receptors, Erythropoietin; Receptors, Interleukin; Severity of Illness Index; T-Lymphocytes, Regulatory; Th17 Cells

2019